Experimental gene therapy seems to alleviate skeletal defects tied to rare inherited disease, study shows; Colorectal cancer is increasing among young people. It’s time to boost research on it

Taking stock of the drug industry, from the lab to the medicine chest

May 1, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Experimental gene therapy seems to alleviate skeletal defects tied to rare inherited disease, study shows A research team showed that the gene therapy, when delivered to toddlers with Hurler syndrome, successfully staved off those problems for years. By Andrew Joseph Opinion: Colorectal cancer is increasing among young people. It's time to boost research on it Young people like Chadwick Boseman are dying of colorectal cancer. More and better research could help reverse that terrible trend. By Simone Ledward-Boseman Opinion: Unnecessary insurance claim denials compromise patient care and provider bottom lines Nearly 15% of all claims submitted to payers for reimbursement were initially denied. More than half were eventually overturned and paid. By Michael J. Alkire

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser